BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Halsey Drug (HDGC) Reports Results For 2003


10/19/2005 5:11:01 PM

Halsey Drug Co., Inc. (OTC.BB-HDGC) today announced that total revenues for the year ended December 31, 2003 decreased to $5,750,000 compared to $8,205,000 for 2002. The Company also reported a net loss for the year ended December 31, 2003 of $48,455,000 or $2.28 per share, compared to a net loss of $59,589,000 or $3.90 per share for 2002. Included in the net loss for 2003 were non-cash expenses of $31,631,000 or $1.49 per share, comprised of $24,771,000 of amortization of debt discount and private offering costs, a $3,619,000 charge for impairment of assets in connection with the restructuring of the Company's operations and $3,241,000 of non-cash interest expense. Non-cash expenses for 2002 were $44,027,000 or $2.88 per share.

Read at press release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES